Health Canada drug identification number

DIN 02389630 — INLYTA 1 MG

INLYTA is a tablet of Axitinib marketed by PFIZER CANADA ULC. The full Axitinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02389630
Brand name
INLYTA
Active ingredient
Axitinib
Strength
1 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Axitinib products

DINBrandStrengthFormManufacturerStatus
02389649 INLYTA 5 MG TABLET PFIZER CANADA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.